BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.3.6//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:1760@azbio.org
DTSTART;TZID=America/Phoenix:20221018T080000
DTEND;TZID=America/Phoenix:20221018T090000
DTSTAMP:20221013T064450Z
URL:https://www.azbio.org/events/azbiopeers-the-ira-is-law-what-comes-next
SUMMARY:AZBioPEERS: The IRA is Law.  What comes next? -  - 18 Oct 22 08:00
DESCRIPTION:\n\n&nbsp\;\nPlease join us for a AZBioPEERS Special Report:\nT
 he IRA is Law.&nbsp\; What Comes Next?\nTuesday\, October 18\, 2022\n\n8:0
 0 am - 9:00 am on Zoom\nREGISTER\nOn August 12\, 2022\, Congress sent the 
 Inflation Reduction Act of 2022 (IRA) to President Joe Biden for signature
  into law.&nbsp\;&nbsp\;The IRA is a 755-page bill that has three primary 
 focus areas: healthcare\, climate\, and taxes.&nbsp\; The legislation pass
 ed on party lines with the Democrats in unified support and the Republican
 s in unified opposition. During the reconciliation process\, Democratic sp
 eakers extolled the good intentions of the IRA programs and the Republican
 s opined on the unintended consequences.\n\nIn this one hour session\, we 
 will explore:\n\n 	The provisions of the IRA that impact the Health Innova
 tion Ecosystem\n 	Unintended consequences of this public policy that are e
 merging\n 	What comes next...\n\nAbout Our Speakers:\n\n\n&nbsp\;\n\nAs Pr
 esident and CEO of AZBio and a member of the AZBio Board of Directors\, Jo
 an Koerber-Walker works on behalf of the Arizona Bioscience and Medical Te
 chnology Industry to support the growth of the industry\, its members and 
 our community on the local and national level. Ms. Koerber-Walker is also 
 a life science investor and has served on the boards of numerous for-profi
 t and non-profit organizations. &nbsp\; (more)\n\n&nbsp\;\n\n&nbsp\;\n\n&n
 bsp\;\n\n\n\nSteven Potts\, PhD&nbsp\; is the founder of the Arizona-based
  biotechs Serpass Biologics and Redrock Science.\n\nSteve has worked in th
 e biopharma industry since 1999 and has had experience in a wide range of 
 areas\, including product development\, sales\, marketing\, and general ma
 nagement. He has a proven track record of success\, and deep experience in
  working with the investor community to build companies that create value 
 for investors and\, more importantly\, for patients.\n\n&nbsp\;\n\n&nbsp\;
 \n\n\n\nLearn more about the IRA by reading Joan's take "Intended &amp\; U
 nintended Consequences" on Page 44 &amp\; 46 in your AZBio Magazine or Cli
 ck&nbsp\; here to view the 2022-2023 AZBio Special Supplement online.\n\nR
 ead what Steve shared on RApport:\nSaving money for Medicare by abandoning
  new drugs for Medicare patients\n&nbsp\;\n&nbsp\;\n&nbsp\;\n&nbsp\;
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20211018T080000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR